Twist Bioscience Corp (TWST) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Twist Bioscience Corp (TWST) has a cash flow conversion efficiency ratio of -0.054x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-24.81 Million) by net assets ($456.10 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Twist Bioscience Corp - Cash Flow Conversion Efficiency Trend (2016–2025)
This chart illustrates how Twist Bioscience Corp's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read Twist Bioscience Corp balance sheet liabilities for a breakdown of total debt and financial obligations.
Twist Bioscience Corp Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Twist Bioscience Corp ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Tikehau Capital
PA:TKO
|
0.074x |
|
Virbac SA
PA:VIRP
|
0.023x |
|
AIR CHINA LTD H ADR/20
F:AD2B
|
N/A |
|
Chengdu Xingrong Investment Co Ltd
SHE:000598
|
0.070x |
|
Upstart Holdings Inc
NASDAQ:UPST
|
0.136x |
|
OPENLANE, Inc.
NYSE:OPLN
|
0.035x |
|
CSSC Steel Structure Engineering Co Ltd
SHG:600072
|
-0.046x |
|
Megacable Holdings S. A. B. de C. V
MX:MEGACPO
|
0.098x |
Annual Cash Flow Conversion Efficiency for Twist Bioscience Corp (2016–2025)
The table below shows the annual cash flow conversion efficiency of Twist Bioscience Corp from 2016 to 2025. For the full company profile with market capitalisation and key ratios, see Twist Bioscience Corp stock valuation.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-09-30 | $472.96 Million | $-47.63 Million | -0.101x | +25.73% |
| 2024-09-30 | $472.69 Million | $-64.09 Million | -0.136x | +40.67% |
| 2023-09-30 | $623.43 Million | $-142.47 Million | -0.229x | -45.03% |
| 2022-09-30 | $789.38 Million | $-124.39 Million | -0.158x | +18.46% |
| 2021-09-30 | $580.82 Million | $-112.24 Million | -0.193x | +54.32% |
| 2020-09-30 | $336.26 Million | $-142.25 Million | -0.423x | +26.84% |
| 2019-09-30 | $152.08 Million | $-87.94 Million | -0.578x | -276.03% |
| 2018-09-30 | $-201.42 Million | $-66.16 Million | 0.328x | -14.61% |
| 2017-09-30 | $-133.36 Million | $-51.30 Million | 0.385x | -23.63% |
| 2016-09-30 | $-76.61 Million | $-38.59 Million | 0.504x | -- |
About Twist Bioscience Corp
Twist Bioscience Corporation manufactures and sells synthetic DNA-based products. The company offers synthetic genes and gene fragments used in product development for therapeutics, diagnostics, chemicals/materials, food/agriculture, data storage, and various applications within academic research by biotech, pharma, industrial chemical, and agricultural companies, as well as academic labs; Oligo … Read more